Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

- Skin sensitisation: No alerts for protein binding are found by 9 (out of nine) QSAR Toolbox 4.1 profilers.

- Skin sensitisation test, in 15 male guinea pigs, Induction: intradermal 1 x 0.05 mL and 9 x 0.1 mL of a 0.1 % solution, Challenge: one intradermal with 0.05 mL of a 0.1% solution, no signs for sensitisation, guideline study, non-GLP.

Key value for chemical safety assessment

Skin sensitisation

Link to relevant study records

Referenceopen allclose all

Endpoint:
skin sensitisation, other
Remarks:
QSAR
Type of information:
(Q)SAR
Adequacy of study:
weight of evidence
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
results derived from a valid (Q)SAR model and falling into its applicability domain, with adequate and reliable documentation / justification
Justification for type of information:
1. SOFTWARE: QSAR Toolbox 4.1

2. MODEL (incl. version number): Skin sensitisation / protein binding profiler of QSAR Toolbox 4.1

3. SMILES OR OTHER IDENTIFIERS USED AS INPUT FOR THE MODEL: CN1CCO[Si](C)(C)C1

4. SCIENTIFIC VALIDITY OF THE (Q)SAR MODEL
[Explain how the model fulfils the OECD principles for (Q)SAR model validation. Consider attaching the QMRF or providing a link]
- Defined endpoint:
- Unambiguous algorithm:
- Defined domain of applicability:
- Appropriate measures of goodness-of-fit and robustness and predictivity:
- Mechanistic interpretation:

5. APPLICABILITY DOMAIN
see attached report

6. ADEQUACY OF THE RESULT
The model provides prediction of chemically-induced skin sensitization. The QSAR Toolbox 4.1 has nine profilers to predict skin sensitisation.
Skin sensitization is initiated by covalent binding of the target substance to skin proteins. The profilers of the QSAR Toolbox 4.1 consider if a
covalent binding of the target molecule and skin proteins is in principle possible, based on mechanistic or empiric reasons. If a covalent binding
is possible based on the structure of the target molecule and a known reaction mechanism an alert for protein binding (skin sensitization) is
reported.
No alerts for protein binding are found by 9 (out of nine) QSAR Toolbox 4.1 profilers.
Principles of method if other than guideline:
QSAR Toolbox 4.1 model.
Key result
Parameter:
other: QSAR
Remarks on result:
no indication of skin sensitisation
Other effects / acceptance of results:
No indication of skin sensitisation.
Interpretation of results:
GHS criteria not met
Conclusions:
No indication of skin sensitisation.
Executive summary:

No alerts for protein binding are found by 9 (out of nine) QSAR Toolbox 4.1 profilers.

According to CLP classification criteria (Regulation (EC) No 1272/2008) a classification is not justified.

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
supporting study
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
documentation insufficient for assessment
Qualifier:
according to guideline
Guideline:
other: Intracutaneous injection with retest according to "APPRAISAL OF THE SAFETY OF CHEMICALS IN FOODS, DRUGS AND COSMETICS, Assoc. of Food and Drug Officials of the United States 1959"
GLP compliance:
no
Remarks:
study conducted prior to implementation of GLP
Type of study:
intracutaneous test
Justification for non-LLNA method:
A test conducted comparable to generally accepted scientific methods with an insufficient documentation is available, which provides data that indicate no sensitizing potential for the test substance. According to REACH Regulation the performance of new animal studies for the purpose of article 17/18 registrations is not mandatory when existing data are available, which were conducted before REACH Regulation entered into force. For this reason and for reasons of animal welfare no additional LLNA was conducted.
Species:
guinea pig
Strain:
Pirbright-Hartley
Remarks:
white
Sex:
male
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: Winkelmann, Kirchborchen, Paderborn
- Weight at study initiation: 300-500 gr
- Diet (e.g. ad libitum): commercial rabbit pellet ration supplemented with greens (kale or lettuce)
Route:
intradermal
Vehicle:
physiological saline
Concentration / amount:
1x 0.05 mL and 9x 0.1 mL of 0.1 % solution
Day(s)/duration:
1 injection per day or 3 per week
Adequacy of induction:
not specified
No.:
#1
Route:
intradermal
Vehicle:
physiological saline
Concentration / amount:
0.05 mL from a 0.1 % solution applied 2 weeks after the last injection from induction
Day(s)/duration:
24h
Adequacy of challenge:
not specified
No. of animals per dose:
15 males
Details on study design:
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 9
- Exposure period: 10-22 days
- Frequency of applications: 1 per day or 3 per week
- Concentrations: 0.1% (1 x 0.05 ml, 8 x 0.1 ml)

B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: 2 weeks after 10th injection
- Concentrations: 0.1% (0.1 ml)
- Evaluation (hr after challenge): 24 hours
Positive control substance(s):
not specified
Key result
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
No. with + reactions:
0
Total no. in group:
15
Remarks on result:
no indication of skin sensitisation

Table 1: Results of the skin sensitisation test

Animal No. Pre-injection Retest
redness score swelling Ø cm redness score swelling Ø cm
927 1 1.5 1 1
929 1 1.1 1 0.5
930 1 0.7 1 0.5
931 1 0.8 1 0.6
932 1 1.0 1 0.4
933 1 0.9 1 0.4
934 1 1.0 1 0.7
935 1 1.1 1 0.5
936 1 1.1 1 0.5
937 1 1.0 1 0.5
938 1 1.0 1 0.5
939 1-2 1.0 1 0.5
940 1 1.0 1 0.5
941 1 1.0 1 0.5
942 1 1.0 1 0.6
Average 1.0 1.0 1.0 0.6
Interpretation of results:
study cannot be used for classification
Conclusions:
In this study the test substance is not a dermal sensitiser.
In a dermal sensitization study according to “APPRAISAL OF THE SAFETY OF CHEMICALS IN FOODS, DRUGS AND COSMETICS, Assoc. of Food and Drug Officials of the United States 1959” with the test substance diluted in isotonic saline, 15 white male guinea pigs were tested.
Executive summary:

In a dermal sensitization study according to “APPRAISAL OF THE SAFETY OF CHEMICALS IN FOODS, DRUGS AND COSMETICS, Assoc. of Food and Drug Officials of the United States 1959” with the test substance diluted in isotonic saline, 15 white male guinea pigs were tested.

 

After dermal induction with 0.1 % solution of test substance, very slight to slight redness was observed in only one animal (#939). All other animals showed only very slight redness during induction. The average swelling was 1.0 Ø cm.

Challenge treatment was performed with the same concentration of 0.1 %. Here, all animals showed only very slight redness. The average swelling was 0.6 Ø cm

 

The test substance is not a dermal sensitiser in this study.

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not sensitising)

Respiratory sensitisation

Endpoint conclusion
Endpoint conclusion:
no study available

Justification for classification or non-classification

Based on the available data, the test substance does not need to be classified for skin sensitisation according to regulation (EC) 1272/2008 (CLP). Data on respiratory sensitisation are not available.